The Yellow Card Scheme is a system operated by the Medicines and Healthcare products Regulatory Agency (MHRA) that collects reports of safety concerns related to healthcare products. Patients can report issues such as side effects, adverse events, defective products, and falsified or fake healthcare products.
These healthcare products include:
• Medicines
• Vaccines
• Medical devices
• Herbal medicines (e.g., medical cannabis)
• Blood products
• E-cigarettes or vapes
The aim of the Yellow Card scheme is to identify any issues with medical products and issue warnings to patients as quickly as possible.
If you are a patient at Curaleaf Clinic and experience any suspected adverse effects related to medical cannabis, you should report any side effects to your specialist clinician during your appointments, contact our team via [email protected] or let us know via your Curaleaf Clinic online account under ‘Report’. We can then report these on your behalf, or you can report them directly if you would prefer.
Anyone is eligible to report concerns related to a medical product through the Yellow Card Scheme. This includes patients, carers, and healthcare professionals.
If you want to report an issue with a medical product to the Yellow Card Scheme, you can do it in several ways.
The MHRA requests that all serious suspected adverse drug reactions (ADRs) are reported to the Yellow Card Scheme along with the following information where relevant: